Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Imunon, Inc. Director's Dealing 2024

Aug 16, 2024

35124_dirs_2024-08-16_c650e301-baaf-4a64-b030-9c9b9a3ca280.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Imunon, Inc. (IMNN)
CIK: 0000749647
Period of Report: 2024-08-15

Reporting Person: Tardugno Michael H (Director, Executive Chairman of Board)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-08-15 Imunon Common Stock P 25000 $1.03 Acquired 353346 Direct

Footnotes

F1: The Chairman purchased the stock on the open market.